Is sotagliflozin better than dapagliflozin? A Pharmacological and Clinical Comparison
•
5 min read
Research indicates that sotagliflozin, a dual SGLT1/SGLT2 inhibitor, may offer specific cardiovascular benefits, such as in post-worsening heart failure, not seen with the SGLT2-selective dapagliflozin. The question of is sotagliflozin better than dapagliflozin depends on the patient's condition, particularly their type of diabetes and specific cardiac risk factors.
